Possible effects of plasminogen activator inhibitor‐1 on promoting angiogenesis through matrix metalloproteinase 9 in advanced mycosis fungoides
Hematological Oncology · 2024
DOI: 10.1002/hon.3244 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hematological Oncology, 2024. Verfasst von Taku Fujimura und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan. Hauptthemen laut MEDLINE: Mycosis Fungoides, Skin Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Mycosis fungoides (MF) progresses slowly before advancing to skin tumors followed by lymph node and visceral involvement. Among MF progression, stage IIB is an initial time point of tumor formation in MF. Since MF in tumor stage possess abundant blood vessels, it is important to evaluate the pro‐angiogenic factors before and after MF in stage IIB. In this report, we investigated pro‐angiogenic soluble factors in MF patients, as well as its pro‐angiogenetic effects on tumor cells and stroma cells. We first evaluated the serum levels of pro‐angiogenic factors in 9 MF patients without tumor formation and 8 MF patients with tumor formation. Among them, the serum MMP‐9 and plasminogen activator inhibitors 1 (PAI‐1) was significantly increased in MF with tumor formation compared in MF without tumor formation, leading to favorable formation of human dermal microvascular endothelial cells tube networks. Moreover, PAI‐1 stimulation significantly increased the mRNA expression and protein production MMP‐9 on monocytes derived M2 macrophages and HUT‐78. Furthermore, since MMP‐9 production from tumor cells as well as stromal cells is suppressed by bexarotene, we evaluate the baseline serum pro‐angiogenic factors including MMP‐9 in 16 patients with advanced cutaneous T cell lymphoma treated with bexarotene. The serum levels of MMP‐2 and MMP‐9 was significantly increased in bexarotene non‐responded patients compared to responded patients. Our present study suggested the significance of MMP‐9 and PAI‐1 for the progression of MF stage toward to the tumor stage, and could be a therapeutic target in future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Tohoku University Graduate School of Medicine, Sendai, Japan.
ORCID-Profile: Taku Fujimura
Förderung
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
Zitieren
APA
Fujimura, T., Ohuchi, K., Ikawa, T., Kambayashi, Y., Amagai, R., Furudate, S., & Asano, Y. (2024). Possible effects of plasminogen activator inhibitor‐1 on promoting angiogenesis through matrix metalloproteinase 9 in advanced mycosis fungoides. Hematological Oncology. https://doi.org/10.1002/hon.3244
Vancouver
Fujimura T, Ohuchi K, Ikawa T, Kambayashi Y, Amagai R, Furudate S, et al. Possible effects of plasminogen activator inhibitor‐1 on promoting angiogenesis through matrix metalloproteinase 9 in advanced mycosis fungoides. Hematological Oncology. 2024. doi:10.1002/hon.3244
BibTeX
@article{Fujimura2024,
author = {Fujimura, Taku and Ohuchi, Kentaro and Ikawa, Tetsuya and Kambayashi, Yumi and Amagai, Ryo and Furudate, Sadanori and Asano, Yoshihide},
title = {Possible effects of plasminogen activator inhibitor‐1 on promoting angiogenesis through matrix metalloproteinase 9 in advanced mycosis fungoides},
journal = {Hematological Oncology},
year = {2024},
doi = {10.1002/hon.3244}
}
EUVIMED